According to a research team in American, a newly discovered hormone could help to improve treatment amongst people with type 2 diabetes . The metabolic hormone, known as Adiponecti, serves to regulate a variety of processes. These include glucose regulation and also the metabolism of fat for energy production.
The recent research showed that the levels of hormone present amongst type 2 diabetics could help to predict the ways in which patients respond to some diabetes drugs .
The study, which is published in the online edition of Clinical Pharmacology and Therapeutics indicates that adiponectin could be used as a biomarker to monitor blood glucose tolerance.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…